CURI vs GAIA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CURI Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CuriosityStream Inc. Class A Common Stock (CURI) driven by superior Valuation, Growth & Margin, Momentum & Technical while GAIA counters with relative strength in Options & Structure. Fundamentally, CURI trades at 6.9x Forward P/E with 10.1% operating margin (+12.9% YoY revenue) versus GAIA at 138.9x Forward P/E and -8.7% operating margin (-11.8% YoY). In options structure, CURI sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro) against GAIA sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CURI Revenue | GAIA Revenue | CURI Op. Margin | GAIA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $40M | N/A | -86.7% | GAIA |
| FY2019 | $20M | $50M | -247.4% | -31.9% | GAIA |
| FY2020 | $40M | $70M | -97.9% | -6.9% | GAIA |
| FY2021 | $70M | $80M | -73.6% | 2.5% | GAIA |
| FY2022 | $80M | $80M | -70.8% | -0.3% | GAIA |
| FY2023 | $60M | $80M | -78.2% | -5.7% | GAIA |
| FY2024 | $50M | $90M | -26.1% | -6.4% | GAIA |
| FY2025 | $70M | $100M | -10.2% | -5.2% | GAIA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CURI | GAIA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $154.9M | $32.3M | Larger Scale | CURI |
| Trailing P/E Ratio Valuation | 17.4x | 138.9x | Lower Multiple | CURI |
| Forward P/E Ratio Valuation | 6.9x | 138.9x | Lower Multiple | CURI |
| Revenue Growth (YoY) Growth | +12.9% | -11.8% | Higher Growth | CURI |
| Operating Margin (TTM) Profitability | 10.1% | -8.7% | Higher Margin | CURI |
| Net Profit Margin Profitability | 11.0% | -8.2% | Higher Margin | CURI |
| Return on Equity (ROE) Capital Efficiency | 19.3% | -8.7% | Higher ROE | CURI |
| 52-Week Range Position Momentum | 9% ($2โ$5) | 2% ($1โ$4) | Stronger Trend | CURI |
| Beta / 30D Volatility Risk Regime | 1.36ฮฒ ยท 99% Vol | 0.50ฮฒ ยท 66% Vol | Lower Realized Risk | GAIA |
| Unified Institutional Score Composite Signal | 52.8 / 100 (HOLD) | 48.5 / 100 (HOLD) | Higher Composite | CURI |